Trialo gives instant access to insights from clinical trial data, aiming to speed up drug development through AI-powered clinical evidence intelligence.
Builder’s Brief
Trialo is a research tool on Falcoscan. Clinical trial evidence intelligence. Falcoscan rates Trialo with an Opportunity score of 76/100 and a Saturation score of 14/100. Trialo is founded in 2025, currently at Pre_seed stage. Pricing: Freemium.
Market position · Research
How Trialo compares in Research
Trialo's opportunity score of 76 ranks #33 of 87 live Research tools on Falcoscan, level with the category average of 75.6. Its saturation score is 14/100, against a category average of 14.3. 33 of the 87 live Research tools carry a hot signal, and Falcoscan has recorded 14 shutdowns in the category.
The top-rated live Research tools on Falcoscan, other than Trialo, are Altos Labs Bio AI, Biorender Scientific AI, Open Alex Research API, Anthropic Constitutional AI, and Undermind Research.
Is Trialo still operating?
Yes. Falcoscan's operating checks list Trialo as active.